Literature DB >> 16261284

Renal amyloidosis: an uncommon complication of juvenile idiopathic arthritis.

Carolina Duarte1, Clara Gomes, A Jorge Correia, Manuel Salgado.   

Abstract

A 9-year-old girl presented with systemic-onset juvenile idiopathic arthritis, diagnosed at 3.5 of age and which was difficult to control despite several therapeutic trials. Five years after diagnosis of juvenile idiopathic arthritis, nephrotic proteinuria was noticed. Renal biopsy confirmed the diagnosis of amyloidosis, and chlorambucil was initiated, with general improvement of the disease and reduction of proteinuria.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16261284     DOI： 10.1007/s10067-005-0048-6

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


  10 in total

1.  Chlorambucil in severe juvenile chronic arthritis: longterm followup with special reference to amyloidosis.

Authors:  H A Savolainen
Journal:  J Rheumatol       Date:  1999-04       Impact factor: 4.666

Review 2.  Amyloidosis in pediatric rheumatic diseases.

Authors:  P Woo
Journal:  J Rheumatol Suppl       Date:  1992-10

Review 3.  Amyloidosis in juvenile chronic arthritis.

Authors:  J David
Journal:  Clin Exp Rheumatol       Date:  1991 Jan-Feb       Impact factor: 4.473

Review 4.  [Systemic forms of idiopathic juvenile arthritis: clinical course].

Authors:  A M Prieur
Journal:  Presse Med       Date:  2000-03-11       Impact factor: 1.228

5.  [Treatment with chlorambucil of renal amyloidosis secondary to rheumatoid arthritis. Study of 6 cases].

Authors:  N R Robles; F Roncero; M Arrobas; J L Alvarez Vega; E Sánchez Casado
Journal:  Med Clin (Barc)       Date:  1999-10-16       Impact factor: 1.725

Review 6.  Treatment of amyloidosis.

Authors:  S Y Tan; M B Pepys; P N Hawkins
Journal:  Am J Kidney Dis       Date:  1995-08       Impact factor: 8.860

7.  Amyloidosis in juvenile chronic arthritis: a morbidity and mortality study.

Authors:  J David; O Vouyiouka; B M Ansell; A Hall; P Woo
Journal:  Clin Exp Rheumatol       Date:  1993 Jan-Feb       Impact factor: 4.473

Review 8.  Musculoskeletal disorders in secondary amyloidosis and hereditary fevers.

Authors:  Gilles Grateau
Journal:  Best Pract Res Clin Rheumatol       Date:  2003-12       Impact factor: 4.098

9.  Simplified quantification of urinary protein excretion in children.

Authors:  J S Elises; P D Griffiths; M D Hocking; C M Taylor; R H White
Journal:  Clin Nephrol       Date:  1988-10       Impact factor: 0.975

10.  Serum amyloid P component scintigraphy and turnover studies for diagnosis and quantitative monitoring of AA amyloidosis in juvenile rheumatoid arthritis.

Authors:  P N Hawkins; S Richardson; D M Vigushin; J David; C R Kelsey; R E Gray; M A Hall; P Woo; J P Lavender; M B Pepys
Journal:  Arthritis Rheum       Date:  1993-06
  10 in total
  3 in total

Review 1.  Successful use of tocilizumab in amyloidosis secondary to systemic juvenile idiopathic arthritis.

Authors:  Ayush Gupta; Narendra Kumar Bagri; Saroj Kumar Tripathy; Adarsh Barwad; Ravi Hari Phulware; Pankaj Hari
Journal:  Rheumatol Int       Date:  2019-07-04       Impact factor: 2.631

2.  Anti-interleukin 1 treatment in secondary amyloidosis associated with autoinflammatory diseases.

Authors:  Rezan Topaloglu; Ezgi Deniz Batu; Diclehan Orhan; Seza Ozen; Nesrin Besbas
Journal:  Pediatr Nephrol       Date:  2015-11-12       Impact factor: 3.714

Review 3.  Clinical improvement of renal amyloidosis in a patient with systemic-onset juvenile idiopathic arthritis who received tocilizumab treatment: a case report and literature review.

Authors:  Songkiat Chantarogh; Soamarat Vilaiyuk; Thipwimol Tim-Aroon; Suchin Worawichawong
Journal:  BMC Nephrol       Date:  2017-05-12       Impact factor: 2.388
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.